April 30, 2025 Uncategorized No Comments Mondego Bio Reports Encouraging Preclinical Outcomes for ZE00-0388 at AACR 2025 Mondego Bio presented new data on its investigational PTPN2 inhibitor ZE00-0388 at the American Association for Cancer Research (AACR) 2025 Annual Meeting, held at the McCormick Place Convention Center in Chicago. Read more
